This newest twist while in the Lykos Therapeutics saga threatens An important overhaul of the business’s method and path, with Musk ally and billionaire investor Antonio Gracias showing to need to get the business again toward its nonprofit drug improvement roots and a far more Doblinite philosophy.Patent purposes are top secret for eighteen mont